ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,482.85
      0.18%
      US Tech 100
      19,392.20
      -0.05%
      Dow Jones
      38,881.02
      0.27%
      Brent Oil
      84.105
      0.24%
      Bitcoin
      64,901.80
      -2.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Orchard Therapeutics PLC (ORTX)

      7. Orchard Therapeutics PLC (ORTX) News

      ORTX Orchard Therapeutics PLC

      16.70
      0.00 (0.00%)
      Last Updated: 20:00:00
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Orchard Therapeutics PLC ORTX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 16.70 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      16.70
      more quote information »

      Recent News

      Date Time Source Heading
      5/07/202407:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
      5/03/202407:00GLOBEOrchard Therapeutics Co-founder and Chief Executive Officer..
      3/20/202407:00GLOBEOrchard Therapeutics Outlines U.S. Launch Plans for..
      3/18/202415:41GLOBEOrchard Therapeutics Receives FDA Approval of Lenmeldy™..
      2/14/202421:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
      2/05/202414:39EDGAR2Form 15-12G - Securities registration termination [Section..
      2/05/202407:00GLOBEOrchard Therapeutics Announces First Patient Randomized in..
      2/02/202407:00GLOBEOrchard Therapeutics Announces Multiple Presentations at the..
      1/31/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      1/25/202407:00GLOBEOrchard Therapeutics Announces Agreement with the Beneluxa..
      1/24/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/24/202416:41EDGAR2Form S-8 POS - Securities to be offered to employees in..
      1/24/202416:28EDGAR2Form POS AM - Post-Effective amendments for registration..
      1/24/202416:17EDGAR2Form 8-K - Current report
      1/24/202405:00GLOBEKyowa Kirin successfully completes acquisition of Orchard..
      1/22/202416:10EDGAR2Form 8-K - Current report
      12/19/202316:49EDGAR2Form 8-K - Current report
      12/11/202307:00GLOBEOrchard Therapeutics Receives Swissmedic Approval for..
      12/08/202316:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      12/08/202316:37EDGAR2Form 8-K - Current report
      11/30/202316:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/30/202316:06EDGAR2Form 8-K - Current report
      11/30/202307:00GLOBEOrchard Therapeutics Receives U.S. FDA Fast Track..
      11/21/202307:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      11/21/202307:51EDGAR2Form 8-K - Current report
      11/16/202316:45EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
      11/13/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/13/202307:05EDGAR2Form 8-K - Current report
      11/13/202307:00GLOBEOrchard Therapeutics Reports Third Quarter 2023 Financial..
      11/03/202317:11EDGAR2Form PREM14A - Preliminary proxy statements relating to..
      10/26/202316:35EDGAR2Form 8-K - Current report
      10/26/202307:00GLOBEOrchard Therapeutics Announces Presentation of Additional..
      10/24/202307:00GLOBEOrchard Therapeutics Announces Multiple Presentations at..
      10/17/202316:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/05/202317:26EDGAR2Form DEFA14C - Additional information statement materials,..
      10/05/202316:48EDGAR2Form DEFA14C - Additional information statement materials,..
      10/05/202316:45EDGAR2Form DEFA14C - Additional information statement materials,..
      10/05/202316:43EDGAR2Form DEFA14C - Additional information statement materials,..
      10/05/202316:40EDGAR2Form DEFA14C - Additional information statement materials,..
      10/05/202309:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/05/202309:05EDGAR2Form 8-K - Current report
      10/05/202307:19IHMARKETNEWSThursday’s Wall Street Highlights: Orchard Therapeutics,..
      10/05/202303:35GLOBEKyowa Kirin to Acquire Orchard Therapeutics
      9/18/202307:07EDGAR2Form 8-K - Current report
      9/18/202307:00GLOBEOrchard Therapeutics Announces Acceptance of Biologics..
      8/31/202307:00GLOBEOrchard Therapeutics Announces Presentation of Data..
      8/21/202316:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
      8/10/202317:04EDGAR2Form S-8 - Securities to be offered to employees in employee..

      Your Recent History

      NASDAQ
      ORTX
      Orchard Therapeutics
      XE
      KMY
      Kimberly Clark
      ASX
      TAHSSI
      Delayed Upgrade Clock